Actively Recruiting

Phase Not Applicable
Age: 15Years - 50Years
All Genders
NCT06796725

Prospective Exploratory Study on rTMS for Migraine Under the Guidance of MEG

Led by Ruijin Hospital · Updated on 2025-02-11

60

Participants Needed

1

Research Sites

72 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Using magnetoencephalography to locate and regulate targets in migraine patients, repeating transcranial magnetic stimulation to physically regulate targets, and evaluating the safety and effectiveness of this treatment method through headache related scales. Using whole genome data and scale scores for correlation analysis, and conducting randomized controls with traditional drugs to explore new approaches for migraine.

CONDITIONS

Official Title

Prospective Exploratory Study on rTMS for Migraine Under the Guidance of MEG

Who Can Participate

Age: 15Years - 50Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Headaches occurring at least 15 days per month for at least 3 months meeting migraine or tension headache criteria
  • Migraine without aura or with aura occurring at least 5 times
  • Headaches relieved by triptan or ergot and not explained by other diagnoses
  • Ability to swallow tablets
  • Signed informed consent and agreement to follow study procedures
Not Eligible

You will not qualify if you...

  • Under 15 years old
  • Optic disc edema, focal neurological symptoms (except typical visual/sensory precursors), or cognitive impairment
  • Sudden, severe headaches that peak rapidly (thunderclap headaches)
  • Fever
  • New onset headaches in adults, especially over 50 years
  • High coagulation risk
  • New headaches in patients with tumor or AIDS history
  • Headaches related to changes in body position
  • History of epileptic seizures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ruijin Hospital

Shanghai, China

Actively Recruiting

Loading map...

Research Team

X

Xiaodan Wang, Doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here